CTRE stock sentiment todayCareTrust REIT, Inc.
Sentiment verdict
Gossip first, financials second — HOT at 85% confidence.
Last updated · cached analysis, refreshes periodically
CTRE
CareTrust REIT, Inc.A high-growth healthcare REIT leveraging a massive acquisition pipeline and best-in-class balance sheet to outperform the SNF sector.
Pick a name and you can add your own 1-, 3- and 6-month price calls — no account needed. The needle above shows where the crowd sits. Calls lock 48 hours after you make them, so every scorecard stays honest.
You'll show up on boards and The Floor under this name. Add an email later to keep your history.
No account needed. You can add an email later to keep your calls.
Already have an account? Sign in
See exactly how analyst targets, gossip sentiment and momentum are weighted into this 6-month forecast.
Sign in to go Pro →Full model breakdown (analyst / gossip / momentum weights) is a Pro feature. Modelled for CTRE. Not financial advice.
Price · last 12 months
Gossip
Market sentiment is highly positive as CTRE is viewed as an 'external growth machine' following a series of record-breaking acquisition quarters. Investors are cheering their ability to raise equity at a premium to NAV to fund accretive deals in a fragmented skilled nursing facility (SNF) market.
- ·Aggressive acquisition pipeline exceeding $1B
- ·Stabilizing operator health post-pandemic
- ·Inclusion in key REIT indices driving passive flows
- ·Recent dividend increases
Financial
CTRE maintains one of the cleanest balance sheets in the REIT sector with a Net Debt to EBITDA ratio around 3.0x-4.0x, providing significant 'dry powder.' Growth in FFO (Funds From Operations) is outpacing peers due to disciplined capital recycling and high-yield deal sourcing.
- ·Net Debt/EBITDA: ~3.7x
- ·Dividend Yield: ~3.0-3.5%
- ·AFFO Growth: Double-digit projected for 2024/25
- ·Payout Ratio: Conservative ~70% range
Conviction
Whose money is actually in the stock — insider open-market trades and the patience of the institutional holder base.
Strong conviction — insiders and patient capital are backing this.
- ·No open-market insider trades in the last 120 days.
Pro shows every named insider trade in the window (buyer, title, size, price, and whether it was a pre-scheduled 10b5-1 sale) plus the full holder register split into patient capital and fast money.
Unlock with Pro →Source: SEC EDGAR Form 4 + 13F holder register. Option exercises, grants, gifts and tax withholding are excluded — only open-market purchases and sales count. Not financial advice.
Risks
- ·Operator concentration (Ensign Group remains a major tenant)
- ·Regulatory risk regarding CMS minimum staffing mandates
- ·Sensitivity to high interest rates impacting cap rate spreads
Peer temperature
How direct competitors stack up against CTRE right now.
- NEUTRALSBRASabra Health Care REIT
COLDER — higher leverage profile and more exposure to struggling senior housing segments compared to CTRE's pure-play SNF focus.
See full analysis → - NEUTRALOHIOmega Healthcare Investors
COLDER — offers a higher yield but lacks CTRE's aggressive growth trajectory and has faced more persistent tenant restructuring issues.
See full analysis → - HOTENSGThe Ensign Group
HOTTER — as an operator rather than a landlord, it captures higher margins from the same industry tailwinds with industry-leading operational efficiency.
See full analysis →
- CTRE-2.7%
- SBRA+0.7%
- OHI-0.8%
- ENSG-7.3%
Analyst price target
Consensus average of 9 analysts · median 45.00
Source: StockAnalysis.com · updated 2026-09-01
AI-generated analysis for informational purposes only. Not financial advice.